Comparing robotic-assisted and conventional knee replacement techniques

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the clinical and economic impacts of Robotic-Assisted Total Knee Replacement (RTKR) versus conventional Total Knee Replacement (TKR). It aims to determine if RTKR offers improved precision and better patient outcomes, as measured by the Forgotten Joint Score and other patient-reported outcome measures. The study is designed as a multicenter, randomized, controlled trial with two treatment arms, focusing on adult patients eligible for knee replacement surgery. Secondary endpoints include activity levels, implant positioning accuracy, and adverse event rates.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Adults aged 18 years and older.
* Eligible for total knee arthroplasty according to local guidelines and routines.
* Willingness to participate in the study.

Exclusion Criteria:

* Patients with extreme malalignment necessitating special implants or techniques.
* Patients unfit for surgery due to other medical reasons.
* Patients who, for other reasons such as alcohol or substance abuse, are deemed unsuitable to participate in the study.
* Patients who, for other reasons, cannot fulfil the required patient-reported outcome measures.

Where it's running

• Hässleholm Hospital
  Hässleholm, Sweden Recruiting
• Danderyd Hospital
  Stockholm, Sweden Recruiting

Study contacts

• Study coordinator: Olof Sköldenberg, MD, PhD
• Email: olof.skoldenberg@ki.se
• Phone: 46+700891253

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Berobenatide for knee pain in adults who are overweight or with obesity

  This study tests berobenatide vs. placebo to see if it reduces knee pain and improves function while helping with weight in adults with knee osteoarthritis and overweight/obesity.

  Recruiting at 7 sites Phase 3 Pfizer · Tempe, Arizona and 39 other locations · NCT07919678

• Adductor canal block versus adductor canal plus IPACK block for pain after total knee replacement

  This study will test whether adding an IPACK block to an adductor canal block reduces pain and the need for pain medicine after total knee replacement.

  Recruiting at 2 sites TC Erciyes University · Kayseri, Talas and 1 other locations · NCT07526831

• 12-month effects of keeping the posterior cruciate ligament during MAKO robotic-assisted total knee replacement

  This trial tests whether keeping the posterior cruciate ligament during MAKO robotic-assisted total knee replacement leads to better function at 12 months for people having a first-time unilateral knee replacement.

  Recruiting at 3 sites Centre Hospitalier Universitaire de Nīmes · Bordeaux and 2 other locations · NCT07489963

• Post-Operative Pain Relief with Zynrelef vs Periarticular Injections in Robot-Assisted Knee Replacement

  This study tests whether the Zynrelef extended-release periarticular injection can reduce pain and opioid use after robot-assisted total knee arthroplasty compared with standard periarticular injections.

  Recruiting Phase 4 Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) · Cranberry Township, Pennsylvania · NCT07430085

• Cryoneurolysis before total knee replacement surgery

  This trial will test whether freezing the genicular nerves at least 24 hours before total knee replacement reduces long-term pain and improves recovery for adults having primary TKA for osteoarthritis.

  Recruiting Attikon Hospital · Athens · NCT07425457

• Single intra-articular injection of celecoxib (AVD275) to check safety and drug levels in knee osteoarthritis.

  This will test a single injection of celecoxib (AVD275) at three different doses in adults with knee osteoarthritis to see if it is safe and how the drug stays in the joint.

  Recruiting Phase 1 Avidence Therapeutics · Wahroonga, New South Wales · NCT07338266

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.